Inamed To Spurn Medicis? Aesthetics Firm Weighs Allergan’s $3.2 Bil. Offer

Inamed is considering a $3.2 bil. unsolicited offer from pharmaceutical specialty firm Allergan after determining that the bid is likely superior to its planned merger with Medicis, the firm announced Nov. 16